Multidrug-resistant pathogens and their plasmid curing by lactic acid bacteria

被引:9
作者
Kiran [1 ]
Kaur, Amanpreet [1 ]
Azmi, Wamik [1 ]
机构
[1] Himachal Pradesh Univ, Dept Biotechnol, Summerhill, Shimla 171005, Himachal Prades, India
来源
ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL | 2021年 / 10卷 / 02期
关键词
Antibiotics; Pathogens; Multidrug resistant; Lactic acid bacteria; Plasmid curing; PENICILLIN-BINDING PROTEINS; MEDIATED DRUG-RESISTANCE; MOBILE GENETIC ELEMENTS; ANTIBIOTIC-RESISTANCE; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; EFFLUX PUMPS; INTRINSIC RESISTANCE; MOLECULAR-MECHANISMS;
D O I
10.21276/ap.2021.10.2.14
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antibiotics are used to treat and prevent infections, but the overuse of drugs makes the microorganisms drug resistant, and with the time they become resistant to more than one drug. These bacteria are known as multidrug-resistant bacteria. Resistivity of bacteria against the antibiotics makes them more hazardous for human beings and animals too and those bacterial infections become untreatable and lead to death of the person. The resistivity to bacteria is provided by the bacterial plasmids, which contains antibiotic resistant genes. This problem can be overcome by removing bacterial plasmids from the bacterial cells. This can be done by treatment with plasmid curing agents, but various plasmid curing agents such as acridine orange or SDS are toxic and mutagenic in nature. Various investigations have been undertaken to determine the antibacterial effect and plasmid curing ability of extracellular and intracellular extracts of lactic acid bacteria (LAB) to cure plasmids of antibiotic resistant bacterial isolates. The microtiter plate method was used to determine the minimum inhibitory concentration of LAB extracts. Plasmid curing mediated by LAB extracts resulted in the loss of antibiotics resistance encoded in plasmids, as well as the antibiotics resistance profile of cured strains. The extracellular extracts of LAB were considered a natural and harmless source to combat plasmid borne multidrug-resistant bacteria.
引用
收藏
页码:101 / 112
页数:12
相关论文
共 50 条
  • [31] A potential plasmid-curing agent, 8-epidiosbulbin E acetate, from Dioscorea bulbifera L. against multidrug-resistant bacteria
    Shriram, Varsha
    Jahagirdar, Sheetal
    Latha, C.
    Kumar, Vinay
    Puranik, Vedavati
    Rojatkar, Supada
    Dhakephalkar, Prashant K.
    Shitole, M. G.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (05) : 405 - 410
  • [32] Spread of Multidrug-Resistant Bacteria and Antibiotic Resistance Genes in a Swine Wastewater Treatment Plant
    Dias, Camila de Paula
    Pereira, Andressa Rezende
    Paranhos, Aline Gomes de Oliveira
    Rodrigues, Marcus Vinicius Duarte
    de Lima, Wanderson Geraldo
    de Aquino, Sergio Francisco
    Silva, Silvana de Queiroz
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH, 2024, 18 (01)
  • [33] Multidrug-resistant Bacteria in a Gynaecology Department
    Dahma, George
    Dumitru, Catalin
    Blaj, Oana
    Bobia, Ana
    Matica, Silvia Iulia
    Oancea, Dennis
    Nitu, Razvan
    Isaq, Amel
    Cosnita, Andrei
    Horhat, Razvan
    Horhat, Ioana Delia
    Moza, Andreea
    PROCEEDINGS OF THE 4TH CONGRESS OF THE ROMANIAN SOCIETY FOR MINIMAL INVASIVE SURGERY IN GINECOLOGY / ANNUAL DAYS OF THE NATIONAL INSTITUTE FOR MOTHER AND CHILD HEALTH ALESSANDRESCU-RUSESCU, 2019, : 207 - 211
  • [34] In Vitro Elimination of Highly Multidrug-Resistant Bacteria by the Lactic Acid Bacterial Drug Candidate ILP100
    Lofton-Tomenius, Hava
    Pang, Yanhong
    Pallin, Anton
    Myktybekova, Zhanar
    Lelham, Ninus
    Riesbeck, Kristian
    Vagesjoe, Evelina
    Roos, Stefan
    Phillipson, Mia
    INFECTIOUS DISEASES AND THERAPY, 2025, : 1119 - 1131
  • [35] Losing ground: multidrug-resistant bacteria in solid-organ transplantation
    Herati, Ramin S.
    Blumberg, Emily A.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (04) : 445 - 449
  • [36] Combating Multidrug-Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
    O'Connell, Kieron M. G.
    Hodgkinson, James T.
    Sore, Hannah F.
    Welch, Martin
    Salmond, George P. C.
    Spring, David R.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (41) : 10706 - 10733
  • [37] The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria
    Li, Grace
    Standing, Joseph F.
    Bielicki, Julia
    Hope, William
    van den Anker, John
    Heath, Paul T.
    Sharland, Mike
    DRUGS, 2017, 77 (09) : 941 - 950
  • [38] Multidrug-Resistant Bacteria in a Gynecology Department
    Dahma, George
    Dumitru, Catalin
    Laj, Oana
    Bobia, Ana
    Matica, Silvia Iulia
    Oancea, Dennis
    Nitu, Razvan
    Horhat, Ioana Delia
    PROCEEDINGS OF SOGR 2018: THE 17TH NATIONAL CONGRESS OF THE ROMANIAN SOCIETY OF OBSTETRICS AND GYNECOLOGY & FIRST ADVANCED COLPOSCOPY COURSE, 2019, : 258 - 262
  • [39] Multidrug-resistant bacteria: what is the threat?
    Bassetti, Matteo
    Righi, Elda
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 428 - 432
  • [40] Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens
    Viertel, Tania Mareike
    Ritter, Klaus
    Horz, Hans-Peter
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2326 - 2336